Literature DB >> 22641300

Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.

Silvio P Neto1, Regina M P Alvarenga, Claudia C F Vasconcelos, Marina P Alvarenga, Luiz C Pinto, Vera L R Pinto.   

Abstract

BACKGROUND: The visual evoked potential (VEP) is used in the evaluation of multiple sclerosis (MS) patients, showing a delay in P100 wave latency with no changes in amplitude in 60-100% of cases. In the last decade, the recurrent form of neuromyelitis optica (NMO) has been recognized, and clinically characterized by acute events of transverse myelitis (TM) and optic neuritis (ON), differing from MS in clinical and laboratory criteria. Despite these differences, so far, the VEP parameters described in MS have been used in the evaluation of patients with NMO. The objective of this study was to investigate VEP responses in NMO.
METHODS: Patients with NMO underwent pattern-reversal visual stimulation. Nineteen patients were selected for the study.
RESULTS: Among the 38 eyes examined, 18 (47.4%) had no visual evoked responses and 13 (34.2%) had a reduction of P100 wave amplitude with normal latency. Only two (5.3%) had the pattern described in MS and five (13.2%) were normal.
CONCLUSION: Evaluation of VEP in patients with definite NMO revealed a pattern that is different from that of MS in 81.6% of eyes examined, characterized by the absence of responses, or decreased amplitude with normal latency.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22641300     DOI: 10.1177/1352458512447597

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  10 in total

1.  First-ever optic neuritis: distinguishing subsequent neuromyelitis optica from multiple sclerosis.

Authors:  Young-Min Lim; So Young Pyun; Hyun Taek Lim; In Hye Jeong; Kwang-Kuk Kim
Journal:  Neurol Sci       Date:  2014-02-01       Impact factor: 3.307

2.  Optical Coherence Tomography versus Visual Evoked Potentials for Detecting Visual Pathway Abnormalities in Patients with Neuromyelitis Optica Spectrum Disorder.

Authors:  Nam Hee Kim; Ho Jin Kim; Cheol Yong Park; Kyoung Sook Jeong; Joong Yang Cho
Journal:  J Clin Neurol       Date:  2018-02-28       Impact factor: 3.077

Review 3.  The electrophysiological assessment of visual function in Multiple Sclerosis.

Authors:  Joshua L Barton; Justin Y Garber; Alexander Klistorner; Michael H Barnett
Journal:  Clin Neurophysiol Pract       Date:  2019-05-08

4.  In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis.

Authors:  Marco Vabanesi; Marco Pisa; Simone Guerrieri; Lucia Moiola; Marta Radaelli; Stefania Medaglini; Vittorio Martinelli; Giancarlo Comi; Letizia Leocani
Journal:  Sci Rep       Date:  2019-07-17       Impact factor: 4.379

Review 5.  Atypical optic neuritis: An overview.

Authors:  Prathama Sarkar; Amit Mehtani; H C Gandhi; Vinita Dubey; Parag Maroti Tembhurde; Mohit Kumar Gupta
Journal:  Indian J Ophthalmol       Date:  2021-01       Impact factor: 1.848

6.  Electrophysiological Study of Visual Pathways in Nevoid Basal Cell Carcinoma Syndrome Patients.

Authors:  Antonietta Moramarco; Ludovico Alisi; Alessandro Lambiase; Sandra Giustini; Luca Lucchino; Emanuele Miraglia; Vincenzo Roberti; Marcella Nebbioso
Journal:  Eye Brain       Date:  2021-03-29

7.  Visual Evoked Potentials in Neuromyelitis Optica Spectrum Disorders.

Authors:  Otto Jesus Hernandez Fustes; Cláudia S K Kay; Paulo José Lorenzoni; Renata D-P Ducci; Lineu C Werneck; Rosana Herminia Scola
Journal:  J Cent Nerv Syst Dis       Date:  2021-12-21

8.  Different visual evoked potentials in neuromyelitis optica spectrum disorder-related optic neuritis and idiopathic demyelinating optic neuritis: a prospective longitudinal analysis.

Authors:  Cong Zheng; Ling Wang; Xiaoyu Xu; Manli Zhou; Kaiqun Liu; Yuxin Zhang; Xiujuan Zhao; Lin Lu; Wei Qiu; Xinyu Zhang; Hui Yang
Journal:  BMC Ophthalmol       Date:  2022-09-21       Impact factor: 2.086

Review 9.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

10.  A descriptive study of prevalence, clinical features and other findings of neuromyelitis optica and neuromyelitis optica spectrum disorder in Khuzestan Province, Iran.

Authors:  Davood Kashipazha; Seyed Ehsan Mohammadianinejad; Nastaran Majdinasab; Mostafa Azizi; Majid Jafari
Journal:  Iran J Neurol       Date:  2015-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.